|
XENE Xenon Pharmaceuticals Inc 1582313 |
| Balance Sheet |
|
Current Assets
|
659,639,000 |
|
Assets
|
835,901,000 |
|
Current Liabilities
|
29,695,000 |
|
Liabilities
|
38,094,000 |
|
Equity
|
797,807,000 |
|
Shares Out
|
75,765,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-127,004,000 |
|
Investing Cash Flow
|
66,497,000 |
| Market Analysis |
Market Cap
|
3,029,064,275 |
|
Price
|
38.52 |
|
BVPS
|
10.53 |
|
PB
|
3.66 |
|
EPS
|
-2.74 |
|
PS
|
0.83 |
|
FCF
|
-60,507,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view XENE documents filed with the SEC.
XENE Filings
Clear
